Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 7 Issue 1, January 2007

From The Editors

Top of page ⤴

Research Highlight

Top of page ⤴

In Brief

Top of page ⤴

Research Highlight

Top of page ⤴

In the News

Top of page ⤴

Research Highlight

Top of page ⤴

In Brief

Top of page ⤴

Review Article

  • The identification of high-risk human papillomavirus types as a necessary cause of cervical cancer offers the possibility of improving cervical cancer detection and prevention. What uncertainties need to be clarified for these possibilities to be realized?

    • Ciaran B. J. Woodman
    • Stuart I. Collins
    • Lawrence S. Young
    Review Article
  • A significant problem in cancer biology is determining the functions of uncharacterized cancer-associated genes discovered from genomic and proteomic datasets. This Review explores how cancer-gene function can be deduced using computational and statsitical methods.

    • Pingzhao Hu
    • Gary Bader
    • Andrew Emili
    Review Article
  • Phenomics is the systematic and meticulous collection, objective documentation and cataloguing of phenotypic data at many levels. This Review describes the possible uses of phenomics in cancer research, using the examples ofRET and PTENphenomics.

    • Kevin M. Zbuk
    • Charis Eng
    Review Article
Top of page ⤴

Opinion

  • Recent data highlight the usefulness of the selective oestrogen-receptor modulators (SERMs) tamoxifen and raloxifene for the prevention of breast cancer. What have we learned about oestrogen modulation, and how can this inform the use of SERMs for both cancer therapy and prevention?

    • V. Craig Jordan
    Opinion
Top of page ⤴

Innovation

  • The Connectivity Map database aims to connect diseases with the genes that cause them and drugs that could treat them. How does this new resource work, and how can it be used by the cancer research community?

    • Justin Lamb
    Innovation
Top of page ⤴

Science and Society

Top of page ⤴

Correspondence

Top of page ⤴

Search

Quick links